Saving changes...

Done

Error

Improving Outcomes for Patients With CLL: Focus on Targeted Therapies and Quality-of-Life Concerns

Improving Outcomes for Patients With CLL: Focus on Targeted Therapies and Quality-of-Life Concerns

Improving Outcomes for Patients With CLL: Focus on Targeted Therapies and Quality-of-Life Concerns

Industry Specialist
Industry Specialist
on behalf of MED-IQ, LLC

FREE
FREE
FREE

FREE
FREE
FREE

null FREE
FREE
FREE
null FREE
FREE
FREE
Normal Price: FREE FREE

Review:

Launch date: 08 Mar 2017
Expiry Date:

Last updated: 13 Mar 2017

Reference: 170719

This course is no longer available

Exam is embedded in the course
No preview available
No Exam Available

Latest User Comments

I would like to...

Course Availability

This course is only available to trainees days after purchase. It would need to be repurchased by the trainee if not completed in the allotted time period. This course is no longer available. You will need to repurchase if you wish to take the course again.

You have null days left.

Description

This Web-based CE activity includes up-to-date information about targeted therapies for CLL and strategies for individualizing treatment. There is also a comprehensive discussion of quality-of-life issues, including suggestions for identifying and managing issues related to physical, cognitive, and emotional well-being for patients living with CLL.

The learner is required to pay a monthly membership fee to the provider in order to take this course.

Objectives

On completion of this course the learner will be able to:
1. Describe targeted therapies for CLL and strategies for individualizing treatment
2. Explain in detail quality-of-life issues
- This includes suggestions for identifying and managing issues related to physical, cognitive, and emotional well-being for patients living with CLL.
Industry Specialist

Author Information Play Video Bio

Industry Specialist
on behalf of MED-IQ, LLC

Thomas LeBlanc, MD, MA
Assistant Professor of Medicine
Division of Hematologic Malignancies and Cellular Therapy
Duke University School of Medicine
Durham, NC

Linda Sutton, MD
Associate Professor of Medicine and Medical Director
Division of Medical Oncology
Duke Cancer Network
Durham, NC

Ivy Altomare, MD
Associate Professor of Medicine
Division of Medical Oncology
Duke Cancer Network
Durham, NC

Michael Choi, MD
Medical Oncologist and Assistant Professor
UC San Diego School of Medicine
Moores Cancer Center
La Jolla, CA

Kerri Dalton, MSN, RN, AOCNS
Associate Director, Education
Duke Cancer Network
Durham, NC

Meredith T. Moorman, PharmD, BCOP, CPP
Hematology/Oncology Clinical Pharmacist
Department of Pharmacy
Duke University Medical Center
Durham, NC

Melanie Watson, MSN, ANP-C
Senior Director, Program Development, Research, and Education
Duke Cancer Network
Durham, NC

Current Accreditations

This course has been certified by or provided by the following Certified Organization/s:

  • Accreditation Council for Pharmacy Education (ACPE)
  • 1.00 Hours -
    Exam Pass Rate: 75
    -
    Reference: to be supplied

Faculty and Disclosures

Additional Contributors

Conflicts Declared

Conflicts of Interest declaration by Author:

null

User Reviews (0)

Go Back

Loading...


Saving changes...

Done

Error